Literature DB >> 32041418

NANOG expression in human development and cancerogenesis.

Gašper Grubelnik1, Emanuela Boštjančič1, Ana Pavlič1, Marina Kos2, Nina Zidar1.   

Abstract

Entities:  

Keywords:  Nanog; cancer; cancerogenesis; development; precancerosis; stem cells

Mesh：

Substances：

Year:  2020        PMID： 32041418      PMCID： PMC7082888          DOI： 10.1177/1535370220905560

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  75 in total

1.  Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma.

Authors:  Junko Matsuoka; Masakazu Yashiro; Katsunobu Sakurai; Naoshi Kubo; Hiroaki Tanaka; Kazuya Muguruma; Tetsuji Sawada; Masaichi Ohira; Kosei Hirakawa
Journal:  J Surg Res       Date:  2010-12-18       Impact factor: 2.192

2.  Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma.

Authors:  Ting Lin; Yan-Qing Ding; Jian-Ming Li
Journal:  Med Oncol       Date:  2011-02-20       Impact factor: 3.064

3.  The human pluripotency gene NANOG/NANOGP8 is expressed in gastric cancer and associated with tumor development.

Authors:  Jingyu Zhang; Xia Wang; Bing Chen; Zhifeng Xiao; Wenmei Li; Youyong Lu; Jianwu Dai
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

4.  Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy.

Authors:  Yu Xia; Tiantian Xu; Changbing Wang; Yinghua Li; Zhengfang Lin; Mingqi Zhao; Bing Zhu
Journal:  Int J Nanomedicine       Date:  2017-12-22

Review 5.  Prognostic significance of NANOG expression in solid tumors: a meta-analysis.

Authors:  Lingqiong Zhao; Jie Liu; Shu Chen; Chun Fang; Xianquan Zhang; Zhibin Luo
Journal:  Onco Targets Ther       Date:  2018-09-06       Impact factor: 4.147

6.  OCT4, SOX2, and NANOG positive expression correlates with poor differentiation, advanced disease stages, and worse overall survival in HER2+ breast cancer patients.

Authors:  Fan Yang; Jiaming Zhang; Hua Yang
Journal:  Onco Targets Ther       Date:  2018-11-06       Impact factor: 4.147

7.  The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders.

Authors:  Juan C de Vicente; Tania Rodríguez-Santamarta; Juan P Rodrigo; Eva Allonca; Aitana Vallina; Anusha Singhania; Paula Donate-Pérez Del Molino; Juana M García-Pedrero
Journal:  J Clin Med       Date:  2019-09-03       Impact factor: 4.241

8.  Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.

Authors:  Liuping You; Xin Guo; Yuenan Huang
Journal:  Yonsei Med J       Date:  2018-01       Impact factor: 2.759

9.  Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas.

Authors:  Arezoo Rasti; Mitra Mehrazma; Zahra Madjd; Maryam Abolhasani; Leili Saeednejad Zanjani; Mojgan Asgari
Journal:  Sci Rep       Date:  2018-08-06       Impact factor: 4.379

10.  Immunohistochemical Expression of Nanog and Its Relation with Clinicopathologic Characteristics in Breast Ductal Carcinoma

Authors:  Omid Emadian Saravi; Farshad Naghshvar; Zhila Torabizadeh; Somayeh Sheidaei
Journal:  Iran Biomed J       Date:  2018-09-17
View more
  10 in total

1.  Expression patterns and clinical significance of the potential cancer stem cell markers OCT4 and NANOG in colorectal cancer patients.

Authors:  Raheleh Roudi; Mahboubeh Barodabi; Zahra Madjd; Giandomenico Roviello; Silvia Paola Corona; Mahshid Panahei
Journal:  Mol Cell Oncol       Date:  2020-07-14

2.  Aryl hydrocarbon receptor blocks aging-induced senescence in the liver and fibroblast cells.

Authors:  Ana Nacarino-Palma; Eva M Rico-Leo; Judith Campisi; Arvind Ramanathan; Francisco J González-Rico; Claudia M Rejano-Gordillo; Ana Ordiales-Talavero; Jaime M Merino; Pedro M Fernández-Salguero
Journal:  Aging (Albany NY)       Date:  2022-05-26       Impact factor: 5.955

3.  MicroRNAs and Long Non-Coding RNAs as Regulators of NANOG Expression in the Development of Oral Squamous Cell Carcinoma.

Authors:  Gašper Grubelnik; Emanuela Boštjančič; Aleksandar Aničin; Tadej Dovšak; Nina Zidar
Journal:  Front Oncol       Date:  2021-02-11       Impact factor: 6.244

4.  FOXC1 Downregulates Nanog Expression by Recruiting HDAC2 to Its Promoter in F9 Cells Treated by Retinoic Acid.

Authors:  Hongni Xue; Fayang Liu; Zhiying Ai; Jie Ke; Mengying Yu; Bingxue Chen; Zekun Guo
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

5.  MicroRNA 630 Represses NANOG Expression through Transcriptional and Post-Transcriptional Regulation in Human Embryonal Carcinoma Cells.

Authors:  Wing-Keung Chu; Li-Man Hung; Chun-Wei Hou; Jan-Kan Chen
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

6.  Evaluation of immunohistochemical expression of stem cell markers (NANOG and CD133) in normal, hyperplastic, and malignant endometrium.

Authors:  Methaq Al-Kaabi; Khalida Noel; Abdal-Jabbar Al-Rubai
Journal:  J Med Life       Date:  2022-01

Review 7.  Ventx Family and Its Functional Similarities with Nanog: Involvement in Embryonic Development and Cancer Progression.

Authors:  Shiv Kumar; Vijay Kumar; Wenchang Li; Jaebong Kim
Journal:  Int J Mol Sci       Date:  2022-03-01       Impact factor: 5.923

Review 8.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Hypopharynx, Larynx, Trachea and Parapharyngeal Space.

Authors:  Nina Zidar; Nina Gale
Journal:  Head Neck Pathol       Date:  2022-03-21

Review 9.  Pleiotropic effects of DCLK1 in cancer and cancer stem cells.

Authors:  Dibyashree Chhetri; Srinivasan Vengadassalapathy; Santhosh Venkadassalapathy; Varadharaju Balachandran; Vidhya Rekha Umapathy; Vishnu Priya Veeraraghavan; Selvaraj Jayaraman; Shankargouda Patil; Ashok Iyaswamy; Kanagaraj Palaniyandi; Dhanavathy Gnanasampanthapandian
Journal:  Front Mol Biosci       Date:  2022-09-26

10.  Expression of NANOG and Its Regulation in Oral Squamous Cell Carcinoma.

Authors:  Gašper Grubelnik; Emanuela Boštjančič; Aleš Grošelj; Nina Zidar
Journal:  Biomed Res Int       Date:  2020-07-17       Impact factor: 3.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.